Replies to post #117511 on Biotech Values

[oc631]

Not a bet I'd want to take on at a $300M market cap although I guess stranger things have happened.

I agree. My guess is the the run-up is mostly retail driven with investors looking to find the next VRUS. Takeover speculation is also fueling interest though premature. Good time for INHX to raise money.